Sight Sciences, Inc. - Common Stock (NQ:SGHT)

8.530 -0.500 (-5.54%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sight Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023

April 13, 2023

The event will include presentations from leading glaucoma surgeons and remarks from the Sight Sciences executive management team

From Sight Sciences, Inc.

Via GlobeNewswire

Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer

April 03, 2023

From Sight Sciences, Inc.

Via GlobeNewswire

Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office

March 30, 2023

From Sight Sciences, Inc.

Via GlobeNewswire

A Preview Of Sight Sciences's Earnings ↗

March 10, 2023

Via Benzinga

Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results

March 13, 2023

From Sight Sciences, Inc.

Via GlobeNewswire

Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System

March 09, 2023

The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures

From Sight Sciences, Inc.

Via GlobeNewswire

Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It ↗

March 09, 2023

Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.

Via Benzinga

Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023

February 23, 2023

From Sight Sciences, Inc.

Via GlobeNewswire

Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference

February 22, 2023

From Sight Sciences, Inc.

Via GlobeNewswire

3 Prime Healthcare Takeover Targets ↗

February 14, 2023

These three companies are attractive targets for their potential.

Via The Motley Fool

Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday ↗

February 10, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Sight Sciences Announces 1,000th TearCare® Customer Installation

January 26, 2023

Over 1,000 Professional Eye Care Practices Have integrated the TearCare® System to Treat Root Cause of Dry Eye Disease due to Meibomian Gland Dysfunction (MGD)

From Sight Sciences, Inc.

Via GlobeNewswire

Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday ↗

January 10, 2023

U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results

January 09, 2023

Company Also Announces CFO Transition

From Sight Sciences, Inc.

Via GlobeNewswire

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Dow Rises Over 300 Points; US Adds 223,000 Jobs In December ↗

January 06, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗

January 06, 2023

Via Benzinga

Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants ↗

December 22, 2022

This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE).

Via Benzinga

Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months

December 08, 2022

From Sight Sciences, Inc.

Via GlobeNewswire

Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference

November 22, 2022

From Sight Sciences, Inc.

Via GlobeNewswire

Unity Software, Amazon, Doximity And Other Big Gainers From Friday ↗

November 14, 2022

U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday ↗

November 14, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 11, 2022

Gainers

Via Benzinga

Dow Turns Higher; Nasdaq Jumps Over 200 Points ↗

November 11, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 60 points on Friday.

Via Benzinga

Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session ↗

November 11, 2022

Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.

Via Benzinga

Nasdaq Surges 100 Points; Crude Oil Rises Sharply ↗

November 11, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining 100 points on Friday.

Via Benzinga

US Stocks Mixed Following Thursday's Rally; Dow Drops 50 Points ↗

November 11, 2022

U.S. stocks traded mixed this morning on Friday, after the Dow Jones jumped 1,200 points in the previous session.

Via Benzinga

Sight Sciences Reports Third Quarter 2022 Financial Results

November 10, 2022

From Sight Sciences, Inc.

Via GlobeNewswire

Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure

November 03, 2022

Multicenter Clinical Data from Five US sites Published in International Ophthalmology

From Sight Sciences, Inc.

Via GlobeNewswire

Earnings Scheduled For November 10, 2022 ↗

November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.